. Author manuscript; available in PMC: 2014 Sep 15.

Published in final edited form as: Int J Cancer. 2013 Mar 29;133(6):1452–1458. doi: 10.1002/ijc.28144

Table 5. Sensitivity analyses 2.

Competing risk regression models for the association between renal function at baseline and long-term risk of cancer diagnosis excluding prostate or breast cancers. Sub-hazard ratio for eGFR<60 mL/min/1.73m² compared to normal or slightly decreased GFR. eGFR estimated from CKD-EPI. Competing risk is death without cancer diagnosis.

	Unadjusted		Adjusted for smoking history and age
	SHR (95% CI)	P value	SHR (95% CI)	P value
Older men	0.84 (0.57, 1.23)	0.4	0.84(0.58, 1.24)	0.4
Younger men	0.88 (0.64, 1.20)	0.4	0.85 (0.62, 1.17)	0.3
Older women	1.02 (0.82, 1.28)	0.8	0.99 (0.79, 1.25)	1
Younger women	1.13 (0.43, 2.97)	0.8	1.11 (0.43, 2.84)	0.8